Igm-2644, a Novel CD38xCD3 Bispecific IgM T Cell Engager Demonstrates Potent Efficacy on Myeloma Cells with an Improved Preclinical Safety Profile
Keyu Li(Sichuan University), Bruce A. Keyt, Paul R. Hinton(IGM Biosciences (United States)), Stephen F. Carroll(IGM Biosciences (United States)), Gene Li(IGM Biosciences (United States)), Rodnie Rosete(IGM Biosciences (United States)), Dean Ng(IGM Biosciences (United States)), Umesh S. Muchhal(IGM Biosciences (United States)), Min Chai(IGM Biosciences (United States)), Poonam Yakkundi(IGM Biosciences (United States)), Angus M. Sinclair(LabGenius (United Kingdom)), Liqin Liu(MacroGenics (United States)), Rui Yun(IGM Biosciences (United States)), Maya F. Kotturi(Alameda Hospital)
Cited by 10
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock
|The Journal of Infectious Diseases|1999|611
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
|Proceedings of the National Academy of Sciences|1986|518
Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution
|Science|1997|360
Structure, Function, and Therapeutic Use of IgM Antibodies
|Antibodies|2020|257